Athira Pharma
ATHA
ATHA
77 hedge funds and large institutions have $64.6M invested in Athira Pharma in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 35 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 83 → 77 (-6)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
57% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 35
Holders
77
Holding in Top 10
2
Calls
$1.09M
Puts
$141K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$2.37M | |
| 3 | +$804K | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$571K |
| 5 |
Renaissance Technologies
New York
|
+$374K |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$1.96M | |
| 3 | -$1,000K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$854K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$659K |